Back

Efficacy of colchicine in reducing cardiovascular events in patients with low-to-normal LDL-C levels

23 April 2026 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Heterogeneity of vascular and atherosclerotic risk phenotypes Biomarkers Delegates Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Mrs Tamar Shengelia

Tbilisi state university clinic VIvamedi, Tbilisi (Georgia)

4 More presentations in this session

Presentation thumbnail
Prognostic impact of total physiologic atherosclerotic burden and residual cholesterol risk in statin-treated patients undergoing PCI
Miss H. Sze (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Which stent wins? Nationwide insights on drug-eluting vs. non-drug-eluting stents in prostate cancer patients undergoing PCI
Doctor V. Sharma (Sayre, US)
Presentation thumbnail
Diagnostic role of aortic valve calcium scoring in aortic stenosis according to etiology
Doctor E. Shirka (Tirana, AL)
Presentation thumbnail
Effect of the ugt1a3*2 haplotype on pharmacokinetics and pharmacodynamics of atorvastatin in patients with coronary heart disease
Ms A. Uduma (Oslo, NO)
Abstract Slides

Access the full session

Session thumbnail
Heterogeneity of vascular and atherosclerotic risk phenotypes

The Event

Event poster

ESC Preventive Cardiology 2026

23 April - 25 April 2026
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Presentation
Implementing cardiac biomarkers in clinical practice: insights from risk stratification with high-sensitivity troponin in asymptomatic individuals

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources